BioSpace News Archive

Biotech Bay

Rigel Announces Reverse Stock Split - June 25, 2024

Rigel Pharmaceuticals, Inc. announced that it will effect a reverse stock split of its issued and outstanding shares of common stock at a ratio of 1-for-10, effective at 12:01 a.m. Eastern Time on Thursday, June 27, 2024.

June 25, 2024
·
5 min read
Business

Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus

Charles River Laboratories International, Inc. today announced a lentiviral vector contract development and manufacturing organization (CDMO) agreement.

June 25, 2024
·
4 min read
Genetown

Foray Bioscience Raises $3M to Protect and Restore Natural Ecosystems with Biomanufacturing

Foray Bioscience , a startup sowing the seeds for plantless plant products, today announced it has raised $3 million in seed funding, led by ReGen Ventures.

June 25, 2024
·
3 min read
Biotech Beach

Dermavant Announces Approval of Tapinarof in both Psoriasis and Atopic Dermatitis in Japan

Dermavant Sciences has received approval in Japan for tapinarof cream, 1% for the treatment of both adults with psoriasis and patients 12 years of age and older with atopic dermatitis.

June 25, 2024
·
5 min read
Business

Industry Leader John Maraganore, Ph.D., Joins Cybrexa Therapeutics as Strategic Advisor

Cybrexa Therapeutics today announced that John Maraganore, Ph.D., has joined as a Strategic Advisor to the Company’s Executive Leadership Team.

June 25, 2024
·
4 min read
BioMidwest

AbbVie Provides U.S. Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa)

AbbVie (NYSE: ABBV) today announced it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for the New Drug Application (NDA) for ABBV-951 (foscarbidopa/foslevodopa) for the treatment of motor fluctuations in adults with advanced Parkinson’s disease.

June 25, 2024
·
3 min read
Pharm Country

Biocodex Microbiota Foundation Announces Open Call For 2024 USA Microbiome Research Grant

The Biocodex Microbiota Foundation is announcing the 2024 open call for applications for its annual USA research grant.

June 25, 2024
·
3 min read
BioMidwest

Endogenex™ Announces $88 Million Series C Financing to Complete Pivotal Trial of the ReCET™ System in Patients with Type 2 Diabetes

Endogenex announced it has closed an oversubscribed Series C financing totaling $88 million.

June 25, 2024
·
3 min read
Business

Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®

Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.

June 25, 2024
·
3 min read
Deals

Oragenics, Inc. Announces Pricing of Public Offering

Oragenics, Inc. today announced that it has entered into a placement agency agreement for the purchase and sale of 1,100,000 shares of its common stock (or pre-funded warrants in lieu thereof) at an offering price of $1.00 per share.

June 25, 2024
·
3 min read